Vanda Pharmaceuticals (VNDA) Tops Q4 EPS by 8c
Tweet
Share
E-mail
Get Alerts VNDA Hot Sheet
Price: $6.05 +0.83%
Revenue Growth %: +17.5%
Financial Fact:
Research and development: 7.29M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +17.5%
Financial Fact:
Research and development: 7.29M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q4 EPS of ($0.01), $0.08 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $38.24 million versus the consensus estimate of $38.39 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
- Ennis (EBF) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
